SUMMARY Lung mucociliary clearance rates were measured in 11 patients with rheumatoid disease and found to be unaltered when compared with those of a group of matched control subjects. The results are discussed in relation to the increased incidence of respiratory infection in patients with rheumatoid disease and also to the recently reported finding of increased airways obstruction in these patients.
Rheumatoid disease is a multisystem disorder and has definite and frequent connections with various types of lung disease. Pleuritic involvement is a common feature and may occur early in the disease process. Nodule formation (with or without cavitation), rheumatoid pneumoconiosis, fibrosing alveolitis, and vascular changes are also recognised.' Upper lobe fibrosis,2 more commonly seen in ankylosing spondylitis, and gold and penicillamine induced lung disease have also been reported. [3] [4] [5] Although less striking, infection is probably the commonest respiratory problem in rheumatoid disease; an increased incidence of pneumonia and bronchiectasis has been found.6-8 Empyema, although uncommon, also has an increased incidence,9
and pulmonary tuberculosis appears with increased frequency.' The increased incidence of chronic bronchitis found in some studies may be due to higher cigarette consumption in the patients than in the appropriate control group.10 No significant increase in emphysema was found in a radiological study by Stack and Grant." Sepsis was the direct cause of death in 20-25 % of patients with rheumatoid disease, of which pneumonia and septicaemia were the most frequent fatal infections.12 13 The lung has 3 defence mechanisms for clearing itself of inhaled particulate matter (including bacteria): lung mucociliary clearance, cough, and alveolar clearance. Alveolar clearance is the slow phase of clearance and concerns the removal of insoluble particles deposited in the alveolar regions and occurs mainly via the alveolar macrophage. Mucociliary clearance of the ciliated or conducting Accepted for publication 22 excluded if they were taking beta-2 agonists and theophylline, both of which are currently thought to alter (enhance) mucociliary clearance rates. 16 The control group contained a similar number (6 females, 5 males) who were either healthy volunteers (9 subjects) or outpatients attending with mild degenerative joint disease (2 subjects). The physical characteristics and mean tobacco consumption of both groups are given in Table 1 . There was no significant difference in these features between the 2 groups. The difference in sex ratio was not thought to be important, as no difference in mucociliary clearance rates between male and female has been found.17 LUNG MUCOCILIARY CLEARANCE Mucociliary clearance was measured by the objective and essentially noninvasive technique (in current use) of Thomson and Short.'8 Polystyrene particles of a uniform diameter (5 ,tm) firmly labelled with 99mtechnetium were generated by the spinning disc technique'9 and inhaled from an airtight tank in 8 separate respiratory manoeuvres of a predetermined volume (450 ml) starting from normal end expiration, using a Krogh spirometer. After inhalation the subject rinsed his mouth with water and swallowed to eliminate any contribution from the mouth, oropharynx, and oesophagus during subsequent counting. The total radiation burden did not exceed 30 ,tCi of 9mtechnetium, resulting in a lung-absorbed dose of 13 mrem. The flow rate during inhalation (which is important in determining the initial distribution of the inhaled particles within the lungs) was measured with a pneumotachygraph.
The distribution of the polystyrene particles was recorded by a rectilinear gamma scanner which travelled in vertical columns at 2-5 cm intervals from the chest midline to the periphery of the seated subject. A 'penetration index' was obtained by relating the count obtained from a central area (near the midline) to a peripheral area as a quantitative measure of the initial topographical distribution of the deposited radio-aerosol.
The subject was then seated between 2 opposing scintillation detectors, one situated anteriorly and the other posteriorly to the chest. Both detectors were suitably collimated to exclude any irradiation originating from swallowed material in the oesophagus or stomach. Counting was taken over 100 seconds at 30-minute intervals for a total of 6 hours and corrected for radioactive decay and background activity. A further count was taken at 24 hours and was considered to be equated with alveolar deposition, that is, deposition beyond the ciliated/ conducting airways.
The subjects were under continual supervision; times of cough and volume and radioactivity of sputum produced were noted; smokers were asked to refrain from cigarette consumption from midnight of the previous day and for the duration of the study. Normal ambulation and activity were continued wherever possible, as was routine medication.
Before the study began all patients underwent routine pulmonary function testing. Table 2 . There was no significant difference between the 2 groups for any of the ventilation indices measured. The depressed values obtained for flow rates at 25% and 50% of vital capacity probably reflect the inclusion of patients who were smokers, as these measurements are an indication of small airways obstruction. Nine of the 11 patients with rheumatoid disease were current or exsmokers, There was no statistically significant difference in the mean tobacco consumption expressed in packyears between the patients and the control subjects (Table 1) . On direct questioning 4 of the 11 patients with rheumatoid disease felt they had exertional dyspnoea, but 3 of these had difficulty in distinguishing this from limitation caused by their disease activity. Two of these patients also had additional ischaemic heart disease. There was no evidence of increased respiratory infections in this group and no evidence of other respiratory illness.
Although the average inhalation flow rate for the particles was slightly higher in the patients with rheumatoid disease than in the control group (36-0 ± 8 6 I/min for the group with rheumatoid disease and 26 i 3 ± 5.4 1/min for the control group), this did not result in a significant difference in the penetration index for the 2 groups (0 59 ± 0 16 and 0 57 ± 0 26, respectively). Unless the distribution of particles within the tracheobronchial tree is comparable in any 2 groups studied, an apparently enhanced whole-lung clearance rate may be explained on the basis of the more rapid clearance of centrally placed particles (which do not have so far to 'travel' as peripheral particles before being 'cleared' by expectoration or swallowing).
The tracheobronchial mucociliary clearance curve (corrected for radioactive decay) for both groups is shown in Fig. 1 . There was no statistically significant difference between the 2 curves when analysed at 2, 4, and 6 hours. As cough during the clearance phase will also contribute to the values obtained, it should be noted that there was no significant difference in the amount ofcoughing or sputum produced between the 2 groups. 
Discussion
It is possible that the increased incidence of infection in patients with rheumatoid disease refers to those patients treated with corticosteroids. Ward and Atcheson'2 showed an increased incidence of urinary tract infections in patients taking more than 7 5 mg prednisone daily, and Talbott and Calkins6 in a post-mortem study of37 patients with rheumatoid disease showed a higher incidence of terminal bronchopneumonia in the corticosteroid treated group. However, these represent a selected group with an increased severity of symptoms, and the general view is that corticosteroids are probably not responsible for the higher incidence of infection. 
